SCHEMBL30976388

SCHEMBL30976388

COc1ccccc1C1(C)CCNCC1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.68
DRD2 P14416 2/20 0.49
CYP2D6 P10635 2/20 0.46
USP2 O75604 1/20 0.46
HTR2C P28335 2/20 0.45
HTR3E A5X5Y0 1/20 0.45
HTR3B O95264 1/20 0.45
ADRB1 P08588 1/20 0.45
CYP2C19 P33261 1/20 0.45
DRD3 P35462 1/20 0.45
HTR3A P46098 1/20 0.45
HTR6 P50406 1/20 0.45
HTR3D Q70Z44 1/20 0.45
HTR3C Q8WXA8 1/20 0.45
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA4 P22748 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1659035 1.00 SIGMAR1 (0.68) SIGMAR1DRD2CYP2D6USP2HTR2C
SCHEMBL19291033 0.87 SIGMAR1 (0.53) SIGMAR1MAPTCA12CA1CA2
SCHEMBL11919524 0.81 SIGMAR1 (0.49) SIGMAR1LMNACA12CA1CA2
SCHEMBL5805869 0.81 SIGMAR1 (1.00) SIGMAR1DRD2CYP2D6USP2HTR2C
SCHEMBL3242340 0.81 SIGMAR1 (0.66) SIGMAR1DRD2CYP2D6USP2HTR2C
SCHEMBL23647452 0.81 SIGMAR1 (0.66) SIGMAR1DRD2CYP2D6USP2HTR2C
SCHEMBL30368868 0.81 SIGMAR1 (1.00) SIGMAR1DRD2CYP2D6USP2HTR2C
SCHEMBL29993586 0.81 SIGMAR1 (0.66) SIGMAR1DRD2CYP2D6USP2HTR2C
SCHEMBL19993072 0.77 DRD2 (0.49) SIGMAR1DRD2DRD3CA12CA1
SCHEMBL615237 0.77 SIGMAR1 (0.60) SIGMAR1DRD2CYP2D6USP2HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4619387-A1 PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE Soley Therapeutics, Inc. (US) 2025-09-24 EP disclosed
WO-2024108131-A1 PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE SOLEY THERAPEUTICS, INC. (US) 2024-05-23 WO disclosed